Default Category
-
Valeant Pharmaceuticals: Eroded Reputation and Stock Price
Mary Gillett; Amy HorrocksCase IVEY-9B20B014-EAccounting and ControlIn early January 2019, a recent Ivey Business School graduate logged into her online trading account to review her portfolio’s performance. As she scanned her investments, she paused at one stock in particular. It was time to make a decision regarding one of her most volatile stocks—Valeant Pharmaceuticals International Inc., recently renamed Bausch Health Companies Inc. The pharmaceutical company was once celebrated for its innovative business a...Starting at €8.20
-
DeepGreen and Polymetallic Nodules
Vietor, Richard H.K.Case HBS-720016-EEconomicsStarting at €8.20
-
Keystone XL Pipeline
Vietor, Richard H.K.Case HBS-713039-EEconomicsTo maximize their effectiveness, color cases should be printed in color. On January 18, 2012, President Obama rejected TransCanada's application for a "national interest" determination to approve construction of the Keystone XL Pipeline. Keystone XL was a 1,700 mile long, 36-inch diameter pipeline to transport 1.1 million barrels a day of Canadian heavy oil from Alberta (and shale oil from Montana) to the American Gulf Coast. But the American env...Starting at €8.20
-
Suncor and the Future of Oil Sands
Vietor, Richard H.K.Case HBS-716065-EEconomicsSuncor, Canada's largest producer of "oil sands," faces a host of issues involving prices, costs, and the environment. The Government of Canada recently put an explicit limit on carbon emissions from oil sands, and a price on carbon. Suncor, which produces more than 400,000 barrels per day of bitumen and synthetic oil must reduce its emissions at the same time that crude oil prices have been dropping. Reduction of cash operating costs, therefore,...Starting at €8.20